Thunderclap headache is the defining clinical clue
RCVS commonly begins with a sudden severe headache that reaches maximal intensity within seconds to a minute. Recurrent thunderclap headaches over several days are particularly suggestive, but RCVS can also present with seizures, focal neurological deficits or complications such as convexity subarachnoid hemorrhage, intracerebral hemorrhage, ischemic stroke or reversible cerebral edema.
A normal early CTA or MRA does not always exclude RCVS
Vasoconstriction can evolve over time and may initially involve smaller distal arteries. CTA or MRA can therefore be nondiagnostic early in the course. If the clinical pattern remains strongly suspicious, specialist reassessment and repeat vascular imaging can be necessary rather than closing the diagnosis after one negative scan.
Dangerous mimics must be excluded first
A first or atypical thunderclap headache requires urgent exclusion of aneurysmal subarachnoid hemorrhage and other acute causes. Depending on the presentation this can include non-contrast CT, CTA/MRA, lumbar puncture, MR venography, vessel-wall imaging and other targeted tests. RCVS should not be diagnosed only because angiography shows arterial narrowing.
RCVS and PACNS can look similar but treatment differs
Primary angiitis of the central nervous system (PACNS) can also cause multifocal intracranial arterial narrowing. Clinical course, CSF, vessel-wall imaging, systemic/infectious work-up and follow-up vascular imaging help separate the two. This distinction matters because immunosuppression may be appropriate for confirmed PACNS but glucocorticoids are not routine RCVS therapy and have been associated with worse RCVS outcomes.
Review medications, drugs and physiological triggers
RCVS is associated with vasoactive medications and substances, the postpartum period and other sympathetic or physiological triggers. A specialist review should include prescription and over-the-counter drugs, serotonergic or sympathomimetic agents, recreational substances, recent pregnancy/postpartum status and the timing of exertion, sexual activity or other recurrent headache triggers.
Calcium-channel blockers are used mainly for symptom control
Nimodipine and sometimes other calcium-channel blockers are commonly used in practice, especially for recurrent severe headache. Evidence that they alter the underlying disease course or prevent stroke is limited. Treatment therefore remains individualized and should not delay investigation of hemorrhage, ischemia or another diagnosis.
Catheter angiography is reserved for selected situations
CTA and MRA are often sufficient for non-invasive follow-up, but digital-subtraction angiography can provide greater vascular detail when the diagnosis remains uncertain or a severe case requires neurointerventional assessment. Intra-arterial vasodilator treatment has been described for selected deteriorating cases but is not routine first-line therapy.
Follow-up imaging is part of confirming reversibility
The syndrome is defined by substantial improvement or resolution of vasoconstriction over time, typically within about three months. Follow-up vascular imaging can therefore be important both for diagnosis and to make sure another persistent arteriopathy has not been mistaken for RCVS.
Charité has a clinically relevant RCVS pathway
Charité's headache research program explicitly includes clinical studies of reversible cerebral vasoconstriction syndrome. Its neurology service also provides outpatient specialist assessment and inpatient care for acute headache syndromes and rare neurological disorders, making it a relevant German center for complex RCVS diagnostic review after emergency stabilization.
What to send for a German RCVS review
The most useful second opinion reconstructs the timing of each headache and the sequence of vascular imaging.
- Emergency CT/CTA images and reports
- Brain MRI including FLAIR, diffusion and susceptibility-sensitive sequences
- MRA/CTA source images from each time point
- Catheter DSA if already performed
- Lumbar-puncture results if obtained
- Exact thunderclap-headache timeline and recurrent triggers
- List of prescription, over-the-counter and recreational vasoactive substances
- Pregnancy/postpartum status when relevant
- Stroke, convexity SAH, PRES or seizure records if complications occurred
- Exact question: confirm RCVS, PACNS differential, medication review, repeat imaging or post-acute follow-up
New thunderclap headache is an emergency symptom
A sudden worst-ever headache, new weakness or speech disturbance, seizure, visual loss, reduced consciousness or suspected intracranial hemorrhage requires immediate local emergency assessment. International RCVS review is appropriate only after urgent causes have been addressed and the patient is clinically stable.
Official sources
Sources last checked 2026-09-05. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.
- Headache research program – RCVS clinical studies — Charité – Universitätsmedizin Berlin ↗
- General Neurology ward – acute headache and rare neurological syndromes — Charité – Universitätsmedizin Berlin ↗
- Cerebral Vasculitis Research – RCVS as a PACNS differential — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Reversible cerebral vasoconstriction syndrome: review of pathogenesis, presentation and treatment — International Journal of Stroke / PubMed ↗
- Treatment-related reversible cerebral vasoconstriction syndrome — Journal of Clinical Medicine / PubMed ↗